1 min read

New Data Shows MR CLEAN Trial Results Extend to at Least Two Years

New Data Shows MR CLEAN Trial Results Extend to at Least Two Years

stent-403500-edited.png

“I think it will help you as a doctor to know you’re doing a treatment not only for 3 months, but that the treatment benefit is going to last for at least 2 years,” said Yvo Roos, MD. “It’s going to help you be more convincing to the relatives that you’re doing the right thing, that you’re doing something that’s really going to help them."

The above quote is in reference to new long-term followup data published as of April 6th, 2017, which now confirms and extends the outcomes of the MR CLEAN endovascular therapy trial in acute ischemic stroke patients.  The results show that 1 out of every 3 patients treated with catheter based intervention are returning home to care for themselves within 3 months and these results are durable up to 2 years! Read the full details of the follow up data right here

LEARN ABOUT PULSARA

Pulsara Around the World - August 2025

Pulsara Around the World - August 2025

July Recap Managing Pre-Planned Events with PulsaraHow do you manage, track, and document hundreds of patient encounters during a large-scale event?...

Read More >>
CommonSpirit Mercy Hospital and EMS Partners Leverage Pulsara for Cardiac Care

CommonSpirit Mercy Hospital and EMS Partners Leverage Pulsara for Cardiac Care

On July 14th, 2025, CommonSpirit Mercy Hospital in Durango, Colorado announced via a press release that they have been partnering with local EMS...

Read More >>
Hurricane Season Readiness: 10 Essential Steps for First Responders

Hurricane Season Readiness: 10 Essential Steps for First Responders

The 2025 hurricane season has arrived, and emergency professionals are watching the forecasts closely. The National Oceanic and Atmospheric...

Read More >>